(Q47419405)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sandro Sorbi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Maria Pia Amato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

E Portaccio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

V Zipoli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

G Siracusa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

446-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Preserving ovarian function in patients receiving cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Long-term safety of azathioprine therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS926OA

10.1191/1352458503MS926OA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14582767%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference